How to improve R&D productivity: the pharmaceutical industry's grand challenge.
The pharmaceutical industry is under growing pressure from a range of environmental issues, including major losses of revenue owing to patent expirations, increasingly cost-constrained healthcare systems and more demanding regulatory requirements. In our view, the key to tackling the challenges such issues pose to both the future viability of the pharmaceutical industry and advances in healthcare is to substantially increase the number and quality of innovative, cost-effective new medicines, without incurring unsustainable R&D costs. However, it is widely acknowledged that trends in industry R&D productivity have been moving in the opposite direction for a number of years. Here, we present a detailed analysis based on comprehensive, recent, industry-wide data to identify the relative contributions of each of the steps in the drug discovery and development process to overall R&D productivity. We then propose specific strategies that could have the most substantial impact in improving R&D productivity.
Paul
Steven M
SM
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. smpaulmd@gmail.com
Mytelka
Daniel S
DS
Dunwiddie
Christopher T
CT
Persinger
Charles C
CC
Munos
Bernard H
BH
Lindborg
Stacy R
SR
Schacht
Aaron L
AL
D002986:Clinical Trials as Topic; D055808:Drug Discovery / Q000379:methods*; D004345:Drug Industry / Q000191:economics* / Q000639:trends; D004526:Efficiency; D006801:Humans; D018803:Models, Economic; D012106:Research / Q000191:economics; D012107:Research Design; D013997:Time Factors